Key facts
- This page summarizes Cynthia L. Feldmann's Form 4 filing for Frequency Therapeutics, Inc. (KRRO).
- 4 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 19 Aug 2022, 16:09.
Cynthia L. Feldmann - 17 Aug 2022 Form 4 Insider Report for Frequency Therapeutics, Inc. (KRRO)
- Reporting relationship
- Director
- Issuer ticker
- KRRO
- Reported as of
- 17 Aug 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 19 Aug 2022, 16:09:12 UTC
- Prior SEC filing
- 05 Aug 2022
- Next SEC filing
- 18 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ James P. Abely, Attorney-in-Fact for Cynthia Feldmann
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Cynthia L. Feldmann filed Form 4 for Frequency Therapeutics, Inc. (KRRO) on 19 Aug 2022.
Change
- Previous filing in this sequence was filed on 05 Aug 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FREQ
transaction
Derivative
Stock Option
Award
- Transaction value
- Shares
- +29,693
- Change %
- Price
- Shares after
- 29,693
- Date
- 17 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 29,693
- Exercise price
- $2.14
- Footnotes
- F1, F2
FREQ
transaction
Derivative
Stock Option
Disposed to Issuer
- Transaction value
- Shares
- -29,693
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 17 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 29,693
- Exercise price
- $20.37
- Footnotes
- F1, F2
FREQ
transaction
Derivative
Stock Option
Award
- Transaction value
- Shares
- +14,846
- Change %
- Price
- Shares after
- 14,846
- Date
- 17 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 14,846
- Exercise price
- $2.14
- Footnotes
- F2, F3
FREQ
transaction
Derivative
Stock Option
Disposed to Issuer
- Transaction value
- Shares
- -14,846
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 17 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 14,846
- Exercise price
- $10.14
- Footnotes
- F2, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The option vests and becomes exercisable in equal monthly installments over a three year period commencing on October 23, 2020, and will be fully vested and exercisable on September 23, 2023.
Footnote F2
The transaction reported herein reflects a one-time stock option repricing that became effective on August 17, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these options.
Footnote F3
The option vested in full on the earlier of June 17, 2022 or the day immediately prior to the company's 2022 annual meeting of shareholders.
Footnote F4
The option vests in full on the earlier of June 17, 2022 or the day immediately prior to the company's 2022 annual meeting of shareholders.